Immutep (IMMP) Share-based Compensation (2011 - 2024)
Immutep's (IMMP) quarterly Share-based Compensation came in at $1.2 million in Q2 2024, down 11.51% YoY from $1.3 million in Q3 2023, and down 11.51% on a QoQ basis from $1.3 million in Q2 2023.
Immutep (IMMP) Share-based Compensation (2011 - 2024) Analysis & Trends
Immutep (IMMP) has 6 years of Share-based Compensation data on file, last reported at $1.2 million in Q2 2024.
- Quarterly Share-based Compensation fell 11.51% year-over-year to $1.2 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $4.2 million (up 36.41% YoY) and the FY2024 annual result came in at $1.2 million, down 11.51% from the prior year.
- Share-based Compensation slipped to $1.2 million in Q2 2024, from $1.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.3 million in Q2 2023 to a low of $1.1 million in Q2 2020.
- A 3-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 11.51% in 2024, down 11.51% in 2024.
- Tracing IMMP's Share-based Compensation over 3 years: stood at $1.1 million in 2020, then gained by 18.37% to $1.3 million in 2023, then decreased by 11.51% to $1.2 million in 2024.
- The last three Share-based Compensation figures came in at $1.2 million (Q2 2024), $1.3 million (Q2 2023), and $1.1 million (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Immutep | 57.14 Mn | -7.95 Mn | - | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Jun 30, 2015 | 574,359.18 |
| Jun 30, 2015 | 574,359.18 |
| Jun 30, 2012 | 55,733.97 |
| Jun 30, 2012 | 55,733.97 |
| Jun 30, 2011 | 44,789.25 |
| Jun 30, 2011 | 44,789.25 |